These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2118712

  • 1. Effects of fluosol-DA on brain edema, energy metabolites, and tissue oxygen content in acute cerebral ischemia.
    Memezawa H, Katayama Y, Shimizu J, Suzuki S, Kashiwagi F, Kamiya T, Terashi A.
    Adv Neurol; 1990; 52():109-18. PubMed ID: 2118712
    [Abstract] [Full Text] [Related]

  • 2. Role of arachidonic acid metabolism on ischemic brain edema and metabolism.
    Katayama Y, Shimizu J, Suzuki S, Memezawa H, Kashiwagi F, Kamiya T, Terashi A.
    Adv Neurol; 1990; 52():105-8. PubMed ID: 2118711
    [Abstract] [Full Text] [Related]

  • 3. Modification of cerebral ischemia with Fluosol.
    Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG.
    Stroke; 1985; 16(1):38-43. PubMed ID: 3966263
    [Abstract] [Full Text] [Related]

  • 4. [Studies on the involvement of bradykinin in the formation of ischemic brain edema].
    Kamiya T.
    Nihon Ika Daigaku Zasshi; 1990 Apr; 57(2):180-91. PubMed ID: 1694863
    [Abstract] [Full Text] [Related]

  • 5. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia.
    Kolluri S, Heros RC, Hedley-Whyte ET, Vonsattel JP, Miller D, Zervas NT.
    Stroke; 1986 Apr; 17(5):976-80. PubMed ID: 3764970
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ, Ishikawa R, Hunter IG, Peerless MJ.
    Stroke; 1981 Apr; 12(5):558-63. PubMed ID: 6795765
    [Abstract] [Full Text] [Related]

  • 7. [Effects of perfluorochemicals on the depressed rCBF and brain metabolism shortly after the hypertensive ICH].
    Iwabuchi T.
    Neurol Med Chir (Tokyo); 1991 Dec; 31(13):867-75. PubMed ID: 1726245
    [Abstract] [Full Text] [Related]

  • 8. Measurements of in vivo energy metabolism in experimental cerebral ischaemia using 31P-NMR for the evaluation of protective effects of perfluorochemicals and glycerol.
    Naruse S, Horikawa Y, Tanaka C, Hirakawa K, Nishikawa H, Watari H.
    Neurol Res; 1984 Dec; 6(4):169-75. PubMed ID: 6152309
    [Abstract] [Full Text] [Related]

  • 9. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S, Handa H, Naruo Y, Oda Y, Yonekawa Y, Takebe Y.
    Neurol Res; 1981 Dec; 3(3):237-50. PubMed ID: 6122175
    [Abstract] [Full Text] [Related]

  • 10. Treatment of cerebral ischemia with Dextran-40 or Fluosol DA 20%.
    Kline RA, Negendank W, McCoy LE.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Dec; 20(2-4):979-83. PubMed ID: 1382645
    [Abstract] [Full Text] [Related]

  • 11. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia.
    Sutherland GR, Farrar JK, Peerless SJ.
    Stroke; 1984 Dec; 15(5):829-35. PubMed ID: 6433517
    [Abstract] [Full Text] [Related]

  • 12. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R, Peerless SJ, Hunter IG.
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [Abstract] [Full Text] [Related]

  • 13. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH, Mang TS, Henderson BW.
    Cancer Res; 1988 Jun 15; 48(12):3350-4. PubMed ID: 3130983
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y, Murata T, Uchida Y, Mori K, Nagasawa S, Naruo Y, Asato R, Handa H.
    No Shinkei Geka; 1982 Jun 15; 10(6):637-44. PubMed ID: 7121730
    [Abstract] [Full Text] [Related]

  • 15. Cumulative effect of repeated ischemia on brain edema in the gerbil. Biochemical and physiological correlates of repeated ischemic insults.
    Nowak TS, Tomida S, Pluta R, Xu S, Kozuka M, Vass K, Wagner HG, Klatzo I.
    Adv Neurol; 1990 Jun 15; 52():1-9. PubMed ID: 2396506
    [Abstract] [Full Text] [Related]

  • 16. [Studies on the effect of Fluosol DA (FC) against acute cerebral ischemia (author's transl)].
    Fujita K, Kusunoki T, Tamaki N, Matsumoto S.
    Neurol Med Chir (Tokyo); 1981 Dec 15; 21(12):1209-13. PubMed ID: 6173782
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the effect of fluosol DA and dextran 40 on regional cerebral blood flow, infarction size, and mortality in cats with temporary occlusion of the middle cerebral artery.
    Kolluri S, Heros RC, Hedley-Whyte ET, Vonsattel JP, Miller D, Zervas NT.
    Surg Neurol; 1986 Jul 15; 26(1):3-8. PubMed ID: 2424107
    [Abstract] [Full Text] [Related]

  • 18. Fluosol-DA, a perfluorochemical oxygen-transport fluid for the management of a trochanteric pressure sore in a Jehovah's Witness.
    Brown AS, Reichman JH, Spence RK.
    Ann Plast Surg; 1984 May 15; 12(5):449-53. PubMed ID: 6742725
    [Abstract] [Full Text] [Related]

  • 19. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW, Ropper AH, Zervas NT.
    Prog Clin Biol Res; 1983 May 15; 122():399-404. PubMed ID: 6348787
    [Abstract] [Full Text] [Related]

  • 20. [The protective effect of mannitol, vitamin E, and glucocorticoid in experimental cerebral ischemia--influence on lipid peroxidation, energy metabolism and brain edema].
    Uenohara H, Imaizumi S, Suzuki J, Yoshimoto T.
    No Shinkei Geka; 1987 Jun 15; 15(6):613-22. PubMed ID: 3118228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.